Haznadar, M., Diehl, C. M., Parker, A. L., Krausz, K. W., Bowman, E. D., Rabibhadana, S., . . . Harris, C. C. (2019). Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev, 28(10), 1704-1711. doi:10.1158/1055-9965.EPI-19-0453

01 Oct 2019
0

Haznadar, M., Diehl, C. M., Parker, A. L., Krausz, K. W., Bowman, E. D., Rabibhadana, S., . . . Harris, C. C. (2019). Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev, 28(10), 1704-1711. doi:10.1158/1055-9965.EPI-19-0453

Tags

Share this

Related Posts

Kheawchaum, S.; Mahidol, C.; Thongnest, S.; Boonsombat, J.; Batsomboon, P.; Sitthimonchai, S.; Ruchirawat, S.; Prawat, H. Ent-abietane Diterpenoid Lactone Glycosides and a Phenolic Glycoside from Phlogacanthus pulcherrimus T. Anderson with Cytotoxic and Cancer Chemopreventive Activities. Phytochemistry 2022, 201, 113261.
Discovery of novel naphthoquinone-chalcone hybrids as potent FGFR1 tyrosine kinase inhibitors: Synthesis, biological evaluation, and molecular modeling

Recent Posts